160
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

A Rare Case of Cervical Squamous Cell Carcinoma Concurrent with Sinonasal Inverted Papilloma: A Case Report

, , &
Pages 1657-1666 | Received 28 Jun 2022, Accepted 17 Nov 2022, Published online: 29 Nov 2022

References

  • Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191–e203. doi:10.1016/S2214-109X(19)30482-6
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
  • Borcoman E, Le Tourneau C. Pembrolizumab in cervical cancer: latest evidence and clinical usefulness. Ther Adv Med Oncol. 2017;9:431–439. doi:10.1177/1758834017708742
  • Bhatla N, Berek JS, Cuello Fredes M, et al. Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri”. Int J Gynaecol Obstet. 2019;147:279–280.
  • Buchwald C, Franzmann MB, Tos M. Sinonasal papillomas: a report of 82 cases in Copenhagen Country, including a longitudinal epidemiological and clinical study. Laryngoscope. 1995;105:72–79. doi:10.1288/00005537-199501000-00016
  • Thompson LDR, Franchi A. New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: nasal cavity, paranasal sinuses and skull base. Virchows Arch. 2018;472:315–330.
  • Strojan P, Ferlito A, Lund VJ, et al. Sinonasal inverted papilloma associated with malignancy: the role of human papillomavirus infection and its implications for radiotherapy. Oral Oncol. 2012;48:216–218. doi:10.1016/j.oraloncology.2011.10.009
  • Lawson W, Ho BT, Shaari CM, Biller HF. Inverted papilloma: a report of 112 cases. Laryngoscope. 1995;105:282–288. doi:10.1288/00005537-199503000-00011
  • Sbrana MF, Borges RFR, Pinna FR, Neto DB, Voegels RL. Sinonasal inverted papilloma: rate of recurrence and malignant transformation in 44 operated patients. Braz J Otorhinolaryngol. 2019;87:80–84. doi:10.1016/j.bjorl.2019.07.003
  • Nudell J, Chiosea S, Thompson LD. Carcinoma ex-Schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature. Head Neck Pathol. 2014;8:269–286. doi:10.1007/s12105-014-0527-7
  • Maroldi R, Farina D, Palvarini L, Lombardi D, Tomenzoli D, Nicolai P. Magnetic resonance imaging findings of inverted papilloma: differential diagnosis with malignant sinonasal tumors. Am J Rhinol Allergy. 2004;18:305–310. doi:10.1177/194589240401800508
  • Schneider SS, Schick C, Fish KE, et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA. 1995;92:3147–3151. doi:10.1073/pnas.92.8.3147
  • Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 1977;1977:1621–1628. doi:10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I
  • Yang D, Wang J, Zhang L. Serum SCCA levels in patients suffering cancers or other diseases. Prog Mol Biol Transl Sci. 2019;162:165–175.
  • Derakhshan S, Poosti A, Razavi AE, et al. Evaluation of squamous cell carcinoma antigen 1 expression in oral squamous cell carcinoma (tumor cells and peritumoral T-lymphocytes) and verrucous carcinoma and comparison with normal oral mucosa. J Appl Oral Sci. 2021;29:e20210374. doi:10.1590/1678-7757-2021-0374
  • Ward N. A mirror of the practice of medicine and surgery in the hospitals of London: London hospital. Lancet. 1854;64:480–482. doi:10.1016/S0140-6736(02)54853-4
  • Deitmer T, Wiener C. Is there an occupational etiology of inverted papilloma of the nose and sinuses? Acta Otolaryngol. 1996;116:762–765. doi:10.3109/00016489609137921
  • Barnes L, Bedetti C. Oncocytic schneiderian papilloma: a reappraisal of cylindrical cell papilloma of the sinonasal tract. Hum Pathol. 1984;15:344–351. doi:10.1016/S0046-8177(84)80033-7
  • Anari S, Carrie S. Sinonasal inverted papilloma: narrative review. J Laryngol Otol. 2010;124:705–715. doi:10.1017/S0022215110000599
  • Goudakos JK, Blioskas S, Nikolaou A, Vlachtsis K, Karkos P, Markou KD. Endoscopic resection of sinonasal inverted papillomas: systematic review and meta-analysis. Am J Rhinol Allergy. 2018;32:167–174. doi:10.1177/1945892418765004
  • Krouse JH. Development of a staging system for inverted papilloma. Laryngoscope. 2000;110:965–968. doi:10.1097/00005537-200006000-00015
  • Cannady SB, Batra PS, Sautter NB, Roh HJ, Citardi MJ. New staging system for sinonasal inverted papilloma in the endoscopic era. Laryngoscope. 2007;117:1283–1287. doi:10.1097/MLG.0b013e31803330f1
  • Minni A, Gera R, Bulgheroni C, et al. Endoscopic resection of sinonasal inverted papilloma: a multivariate retrospective analysis of factors affecting recurrence and persistence. Ear Nose Throat J. 2021;100:542S–548S. doi:10.1177/0145561319890454
  • Yasumatsu R, Nakashima T, Kuratomi Y, et al. Serum squamous cell carcinoma antigen is a useful biologic marker in patients with inverted papillomas of the sinonasal tract. Cancer. 2002;94:152–158. doi:10.1002/cncr.10144
  • Yasumatsu R, Nakashima T, Masuda M, et al. Clinical value of serum squamous cell carcinoma antigen in the management of sinonasal inverted papilloma. Head Neck. 2005;27:44–48. doi:10.1002/hed.20115
  • Suzuki M, Deng Z, Hasegawa M, Uehara T, Kiyuna A, Maeda H. Squamous cell carcinoma antigen production in nasal inverted papilloma. Am J Rhinol Allergy. 2012;26:365–370. doi:10.2500/ajra.2012.26.3797
  • Matoušek P, Zeleník K, Safarčík K, Cábalová L, Komínek P. Squamous cell carcinoma antigen as a marker of sinonasal inverted papilloma. Eur Arch Otorhinolaryngol. 2014;271:535–538. doi:10.1007/s00405-013-2604-z
  • Yamashita Y, Uehara T, Hasegawa M, et al. Squamous cell carcinoma antigen as a diagnostic marker of nasal inverted papilloma. Am J Rhinol Allergy. 2016;30:122–127. doi:10.2500/ajra.2016.30.4287
  • van Zijl FVWJ, Monserez DA, Korevaar TIM, et al. Postoperative value of serum squamous cell carcinoma antigen as a predictor of recurrence in sinonasal inverted papilloma. Clin Otolaryngol. 2017;42:528–535. doi:10.1111/coa.12757
  • Yasumatsu R, Nakano T, Sato M, et al. Combination of serum squamous cell carcinoma antigens 1 and 2 as potential diagnostic marker for sinonasal squamous cell carcinoma and inverted papilloma. Head Neck. 2018;40:2583–2589. doi:10.1002/hed.25351
  • Hsu KF, Huang SC, Shiau AL, et al. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer. Int J Gynecol Cancer. 2007;17:174–181. doi:10.1111/j.1525-1438.2006.00663.x
  • Gheit T. Mucosal and cutaneous human papillomavirus infections and cancer biology. Front Oncol. 2019;9:355. doi:10.3389/fonc.2019.00355
  • de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664–670. doi:10.1002/ijc.30716
  • Gupta R, Rady PL, Sikora AG, Tyring SK. The role of human papillomavirus in the pathogenesis of sinonasal inverted papilloma: a narrative review. Rev Med Virol. 2021;31:e2178. doi:10.1002/rmv.2178
  • Pähler Vor der Holte A, Fangk I, Glombitza S, Wilkens L, Welkoborsky HJ. Prognostic factors and risk factors for development and recurrence of sinonasal papillomas: potential role of different HPV subtypes. Eur Arch Otorhinolaryngol. 2020;277:767–775. doi:10.1007/s00405-019-05747-4
  • Sánchez-Vargas LO, Díaz-Hernández C, Martinez-Martinez A. Detection of human papilloma virus (HPV) in oral mucosa of women with cervical lesions and their relation to oral sex practices. Infect Agent Cancer. 2010;5:25. doi:10.1186/1750-9378-5-25